Geron reported $122.14M in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Amgen USD 57.3B 19M Jun/2026
Bio Techne USD 200M 0 Jun/2026
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 1.27B 18.17M Jun/2026
Exelixis USD 162.2M 3.73M Sep/2026
Genmab DKK 5.35B 5.2B Mar/2026
Geron USD 122.14M 78K Jun/2026
Gilead Sciences USD 26.25B 4.07B Jun/2026
Incyte USD 38.27M 1.16M Jun/2026
MacroGenics USD 35.09M 1.42M Jun/2026
Novartis USD 49.01B 2.02B Jun/2026
Novavax USD 233.31M 4.23M Sep/2024